Consequently, simultaneous tumor therapy with Sapanisertib + IR in the irradiation field would lead to strong mTOR inhibition and hardly affect mTOR activity in the surrounding healthy tissue, whereas CC-115 would lead to a decrease in mTOR activity throughout the body and thus also impair processes such as cell proliferation and cell differentiation in healthy body cells. This evidence concerns the gene MTOR and neoplasm.